Table 2.
Clinical data of patients with multiple sclerosis (n=1,404)
| Annualized relapse rate, range (mean ± SD) | 0.5–4 (0.86±0.69) |
| Presenting symptoms, n (%) | |
| Motor | 616 (43.87) |
| Superficial sensory | 465 (33.12) |
| Visual (optic) | 392 (27.92) |
| Ataxia | 302 (21.51) |
| Diplopia (oculomotor) | 122 (8.69) |
| Unusual presentation (n=54, 3.85%) | |
| Cognitive deficit | 13 (0.93) |
| Seizure disorders | 12 (0.85) |
| Behavioral | 8 (0.57) |
| Sexual dysfunction | 6 (0.43) |
| Depression | 6 (0.43) |
| Dystonia | 5 (0.36) |
| Disturbed consciousness | 2 (0.14) |
| Excessive daytime sleepiness | 2 (0.14) |
| Initial EDSS, range, mean ± SD, median | 0.5–8.5, 2.85±1.44, 3 |
| Last assessed EDSS, range, mean ± SD, median | 1–10, 4.65±1.98, 3.5 |
| Duration to treatment (months), range, mean ± SD, median | 1–266.8, 31.7±42.1, 26.01 |
| Family history, n (%) | |
| Multiple sclerosis | 32 (2.28) |
| Other autoimmune diseases | 54 (3.85) |
Abbreviation: EDSS, Expanded Disability Status Scale.